Added to YB: 2025-10-28
Pitch date: 2025-10-24
RIG2.MU [bullish]
Gedeon Richter PLC
Author Info
Ridire Research is an independent equity research platform focused on actionable, high-conviction long/short equity ideas. We combine fundamental rigor with quantitative structure to identify mispriced opportunities others overlook. Sign up for the newsletter.
Company Info
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. It offers women’s healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids; and Femtech, a digital therapeutic solution to enhance women’s lives.
Market Cap
HUF 2.2T
Pitch Price
N/A
Price Target
N/A
Dividend
4.14%
EV/EBITDA
5.52
P/E
9.77
EV/Sales
2.17
Sector
Pharmaceuticals
Category
growth
Gedeon Richter (RICHT) — CNS Royalty + Women’s Health
RIG2.MU: Hungarian pharma w/ dual moats: mid-teens royalty on $2.7B Vraylar antipsychotic (patents to 2030+) + proprietary steroid chemistry driving women's health franchise. Net cash, 100+ countries, self-sufficient manufacturing. Risks: patent cliff post-2030, EU pricing pressure.
Read full article (4 min)